The average price of menstrual products like tampons and pads has increased nearly 40% since 2020, driven by rising inflation, tariffs, and supply chain costs. This price surge has led to a nearly 6% decline in sales as consumers, especially those with limited budgets, look for cheaper or reusable alternatives. Tariffs on imports from countries like China, Canada, and Mexico, along with sales taxes in some states, add to the cost burden. The trend is encouraging growth in reusable menstrual products, which offer long-term savings and environmental benefits, while major brands face pressure to adjust pricing and product strategies.
Aetna's latest survey shows U.S. healthcare providers' trust in payers increased to a score of 6.1 from 5.4, reflecting improved perceptions of payer reliability and communication. Providers highlight technology's role in reducing administrative task...
CVS Caremark announced a global settlement with the Federal Trade Commission (FTC) resolving all litigation related to rebate practices, pharmacy network contracting, and vertical integration. The agreement ends ongoing investigations and allows CVS ...
